RusnanoMedInvest is a private equity general partner firm headquartered in Moscow, Russia.
Syndax Pharmaceuticals, a biopharmaceutical company focused on treating cancer, closed $80m in Series C funding from OrbiMed and others.
Selecta Biosciences, an antigen-specific immune therapies developer, has raised $20m from Polaris Venture Partners and others.
Clearside Biomedical has raised $16m in Series B funds from RusnanoMedInvest, Hatteras Venture Partners, Mountain Group Capital and others.
Read more news concerning RusnanoMedInvest
A sampling of RusnanoMedInvest portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?